KALA
Kala Pharmaceuticals Inc
Price:  
6.70 
USD
Volume:  
42,003.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KALA WACC - Weighted Average Cost of Capital

The WACC of Kala Pharmaceuticals Inc (KALA) is 5.9%.

The Cost of Equity of Kala Pharmaceuticals Inc (KALA) is 7.75%.
The Cost of Debt of Kala Pharmaceuticals Inc (KALA) is 5.00%.

Range Selected
Cost of equity 6.30% - 9.20% 7.75%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.1% - 6.7% 5.9%
WACC

KALA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.54 0.78
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.30% 9.20%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.86 0.86
Cost of debt 5.00% 5.00%
After-tax WACC 5.1% 6.7%
Selected WACC 5.9%